(Registrieren)

EANS-News: Symrise AG / Symrise reports double-digit growth in both divisions and in all regions

Geschrieben am 09-11-2010



• Group sales grow by 16.4 %

• Emerging markets account for 46 % of sales

• Profitability rises disproportionate to sales, EBITDA margin

at 22.2 %

• Objectives for 2010 will be achieved



--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------


9-month report

Subtitle:
• Group sales grow by 16.4 %
• Emerging markets account for 46 % of sales
• Profitability rises disproportionate to sales, EBITDA margin
at 22.2 %
• Objectives for 2010 will be achieved

Holzminden, November 9, 2010 (euro adhoc) - Following the dynamic
development of business in the first half of the year, Symrise AG
continued to benefit from the economic recovery in important markets
in the third quarter. The positive development was driven by solid
consumer confidence in established markets and an ongoing high demand
in emerging markets. During the nine-month period Symrise saw sales
grow by 16.4 % (12.4 % at local currency), thereby again growing
faster than the market for flavors and fragrances. The Group EBITDA
rose 40 % to EUR 267.7 million and the EBITDA margin improved from
18.4 % to 22.2 %. The strong sales growth, a high utilization of
production capacities and ongoing cost awareness contributed
significantly to the positive earnings development.

Dr. Heinz-Jürgen Bertram, Chief Executive Officer of Symrise AG,
said: "During the first nine months, Symrise achieved a double-digit
growth rate in both divisions and in all regions. Our broad
international presence and firm foothold in emerging markets have
paid off once again. Business with global customers in both divisions
is growing at an above-average rate. The Scent & Care division in
particular benefits from an increased demand in the luxury segment.
In view of the excellent development of business during the first
nine months, we are confident that Symrise will achieve its goals set
for the full year."

Bertram added: "We are keeping our strategic objectives firmly in
focus. We plan to further sharpen the profile of Symrise and place
special emphasis on the development of new products in the rapidly
growing segments of Life Essentials and Consumer Health. We will also
continue to expand our presence in emerging markets."

Symrise expects to achieve an organic growth rate of more than 8 % at
local currency for the full year 2010 even though growth has slowed
down slightly in the third quarter, as expected. Assuming that raw
material prices will rise moderately and will only have a minor
impact on manufacturing costs, the company continues to aim at an
EBITDA margin of more than 20 %. The management also confirms the
objective of further reducing the ratio of net debt (incl. pension
provisions) to EBITDA to a level of around 2.5.

Double-digit sales growth in all regions In the first three quarters
of 2010 Symrise increased Group sales by 16.4 % (12.4 % at local
currency) from EUR 1,037.5 million to EUR 1,207.7 million. The Group
enjoyed strong demand in established as well as in emerging markets.

The Asia/Pacific region was the most important growth engine with an
increase in sales of 23 % (13 % at local currency). All application
areas performed strongly here. Latin America accounted for the
second-highest growth rate of 19 % (13 % at local currency) despite
the strong performance in the corresponding period of the previous
year. Group sales in North America rose by 17 % (13 % at local
currency) and benefited primarily from the strong demand in Fine
Fragrances and Household. In the EAME region, which had suffered the
most from the economic crisis in the previous year, sales grew
significantly by 13 % (12 % at local currency) due to, among others,
the strong demand in Life Essentials as well as in Middle East and
Africa.

Scent & Care catching up in business with key customers Both
divisions enjoyed above-average growth in business with key
customers. During the first nine months sales generated with this
customer group rose by 14.6 % at local currency. Major customers
overall accounted for approx. 30 % of Group sales.

Scent & Care reported an increase of 14.6 % in sales with key
customers compared to last year, thereby equaling the 14.5 % rise in
sales posted by Flavor & Nutrition. Both divisions solidified their
positions as core suppliers to major multinational consumer goods
manufacturers by winning new projects. EBITDA grows by 40 % - EBITDA
margin rises to 22.2 %

A recovery in demand and high production capacity utilization had a
significant impact on the earnings development of Symrise in the
first three quarters of 2010. Furthermore, Symrise benefited from
ongoing cost awareness. The costs of raw materials and manufacturing
remained stable in comparison to the same period of last year.

Symrise achieved a 40 % increase in earnings before interest, taxes
and depreciation (EBITDA) from EUR 190.8 million to EUR 267.7
million. The EBITDA margin reached a high level of 22.2 % (previous
year: 18.4 %). Despite negative currency effects, net profit for the
period grew by 81 % to EUR 127.3 million (previous year: EUR 70.4
million). This corresponds to an increase in earnings per share from
EUR 0.60 to EUR 1.08.

Cash flow from operating activities higher than last year despite
increase in working capital Symrise saw cash flow from operating
activities rise from EUR 145.0 million to EUR 155.6 million during
the reporting period. The Group was able to more than compensate for
the increase in working capital caused by the strong operating
business. The ratio of net debt incl. pension provisions to EBITDA
declined from 3.1 at the end of 2009 to 2.3 as of September 30, 2010.

At the beginning of the fourth quarter, Symrise initiated the
refinancing of its existing bullet loan financing in the amount of
EUR 550 million that would fall due at the end of 2011. The
refinancing aims at an early redemption of existing debt and the
establishment of a longer-term financing for the company. In addition
to obtaining a senior term note of US$ 175 million from US investor
Prudential (Pricoa), Symrise generated proceeds in the amount of EUR
300 million through its first bond issue. Negotiations with banks
about a revolving credit facility are expected to be completed by the
end of 2010. This will conclude the Group´s refinancing efforts.

Scent & Care - sales grow by approximately 20 % Scent & Care reported
strong demand in all application areas. Fine Fragrances and Personal
Care, which were hit hard by the economic downturn during the
previous year, performed particularly well. Scent & Care completed an
important investment project with the expansion of production
capacity for perfume oils by 25 % in the third quarter. The division
also launched new products in the application areas Oral Care and
Fragrance Ingredients.

Scent & Care achieved double-digit growth in all regions even though
the growth dynamics slowed down slightly in the third quarter. The
division enjoyed its sharpest rise in sales of 17 % (at local
currency) in the EAME region, followed by the North America with 15 %
(at local currency) and Asia/Pacific with 13 % (at local currency).
Sales in Latin America remained on a high level with a growth rate of
11 % (at local currency), although growth was more moderate due to
strong prior-year comparables.

Sales of Scent & Care grew by approximately 20 % (14.7 % at local
currency) to EUR 621.8 million (previous year: EUR 518.6 million).
The EBITDA rose 54 % to EUR 131.2 million (previous year: EUR 85.0
million), whereby the EBITDA margin increased to 21.1 % over 16.4 %
for the same period of last year.

Flavor & Nutrition - highly profitable with an EBITDA margin of 23.3
% The Flavor & Nutrition division also enjoyed high demand in all
application areas with a particularly strong development in Sweets
and Beverages. Business developed most dynamically in Latin America.
Flavor & Nutrition achieved a 15 % increase in sales (at local
currency), which was particularly driven by strong business with
international and local key customers. The Asia/Pacific region posted
the second-highest increase in sales of 13 % (at local currency)
primarily due to the high demand in Beverages. Both, North America
and the EAME region posted a 9 % growth in sales (at local currency).
Products from the application areas Sweet and Savory were the primary
growth engines in North America. Symrise also concluded new supplier
contracts for vanilla flavors and seasonings in North America. In the
EAME region, Flavor & Nutrition benefited mainly from the
above-average growth rate for soft drinks and alcoholic beverages,
among others from an increasing demand for mixed beer beverages.

Segment sales during the reporting period rose 12.9 % (10.2 % at
local currency) to EUR 586.0 million (previous year: EUR 518.9
million). The EBITDA improved by 29 % to EUR 136.5 million (previous
year: EUR 105.8 million). The EBITDA margin attained the excellent
level of 23.3 %.

In EUR millions


9 M 2009 9 M 2010 Change in % Change in % at LC
Sales 1,037.5 1,207.7 16.4 12.4
EBITDA 190.8 267.7 40 37
EBITDA margin in % 18.4 22.2 - -
EBIT 130.9 202.1 54 51
EBIT margin in % 12.6 16.7 - -
Net income
for the period 70.4 127.3 81 -
EPS in EUR 0.60 1.08 81 -
Cash flow from
operating activities 145.0 155.6 - -

Divisions
Scent & Care
Sales 518.6 621.8 19.9 14.7
EBITDA 85.0 131.2 54 50
EBITDA margin in % 16.4 21.1 - -

Flavor & Nutrition
Sales 518.9 586.0 12.9 10.2
EBITDA 105.8 136.5 29 27
EBITDA margin in % 20.4 23.3 - -


31 Dec. 09 30 Sep. 10
Balance sheet total 1,895.2 2,033.8
Equity ratio in % 36.4 39.4
Net debt (incl. pension
provisions)/EBITDA 3.1 2.3
Employees/FTE¹ 4,954 5,225


¹Excluding apprentices and trainees, FTE = Full Time Equivalent
(full-time employees)

About Symrise

Symrise is a global supplier of fragrances and flavorings while also
manufacturing raw materials and active ingredients for the perfume,
cosmetics and food industries.

Its sales of EUR 1.36 billion in 2009 place the company among the top
four in the international flavors and fragrances market.
Headquartered in Holzminden, Germany, Symrise is represented in over
35 countries in Europe, Asia, the United States and South America.

Used by manufacturers of perfumes, cosmetics and foods, our products
are an inseparable part of daily life. At Symrise, we combine an
awareness of consumer trends with cutting-edge technologies, focusing
on innovative fashion and lifestyle products that have additional
practical value for the consumer. Symrise - always inspiring more…
www.symrise.com


end of announcement euro adhoc
--------------------------------------------------------------------------------


ots Originaltext: Symrise AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Press contact:

Bernhard Kott

Phone: +49 (0) 55 31 90-17 21

bernhard.kott@symrise.com

Branche: Chemicals
ISIN: DE000SYM9999
WKN: SYM999
Index: MDAX
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

299568

weitere Artikel:
  • EANS-News: Symrise AG / Symrise wächst in beiden Geschäftsbereichen und in allen Regionen zweistellig • Steigerung des Konzernumsatzes um 16,4 % • Schwellenländer stehen für 46 % des Umsatzes • Profitabilität steigt überproportional zum Umsatz, EBITDA-Marge von 22,2 % • Ziele für 2010 werden erreicht -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- 9-Monatsbericht Utl.: • mehr...

  • Norbert Kickum retires from the Management Board of Aareal Bank AG Wiesbaden (ots) - - Querverweis: Ein Dokument liegt in der digitalen Pressemappe zum Download vor und ist unter http://www.presseportal.de/dokumente abrufbar - Norbert Kickum, who, as a member of the Management Board, has been responsible for Aareal Bank's property financing business on international markets, has left the bank with effect from 31 October 2010. His departure is for purely personal reasons, by amicable and mutual consent. Aareal Bank will announce a successor shortly. Norbert Kickum has been mehr...

  • Kickum aus Vorstand der Aareal Bank ausgeschieden Wiesbaden (ots) - - Querverweis: Ein Dokument liegt in der digitalen Pressemappe zum Download vor und ist unter http://www.presseportal.de/dokumente abrufbar - Norbert Kickum, bisher im Vorstand der Aareal Bank AG für Immobilienfinanzierungen auf den internationalen Märkten verantwortlich, hat das Institut mit Wirkung zum 31. Oktober 2010 aus persönlichen Gründen und im besten gegenseitigen Einvernehmen verlassen. Seinen Nachfolger wird die Aareal Bank in Kürze bekannt geben. Norbert Kickum gehörte dem mehr...

  • EANS-Adhoc: Intercell AG announces Q3 2010 results and updates on R&D progress and management -------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 9-month report 09.11.2010 Positive sales trend of IXIARO®/JESPECT® vaccine against Japanese Encephalitis - Focused R&D spending on late-stage programs and negative currency effects lead to EUR 27.8m loss mehr...

  • EANS-Adhoc: Intercell AG gibt Ergebnisse für das 3. Quartal 2010 und aktuellen Überblick über F&E-Fortschritte und Management-Team bekannt -------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. -------------------------------------------------------------------------------- 9-Monatsbericht 09.11.2010 Positiver Umsatztrend beim Impfstoff gegen Japanische Enzephalitis, IXIARO®/JESPECT®, setzt sich fort - Gezielte F&E-Ausgaben für fortgeschrittene Programme und negative Währungseffekte führen zu mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht